Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Progress in Nuclear Magnetic Resonance Spectroscopy
|
September 17, 2011
In-cell NMR spectroscopy
Andres Y Maldonado, David S Burz, Alexander Shekhtman
Plos One
|
September 17, 2013
Fate of pup inside the Mycobacterium proteasome studied by in-cell NMR
Andres Y Maldonado, David S Burz, Sergey Reverdatto, et al.
The Journal of Biological Chemistry
|
December 24, 2011
Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1
Vivek Rai, Andres Y Maldonado, David S Burz, et al.
Nature Communications
|
November 19, 2014
Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
Benjamin Israelow, Gavriel Mullokandov, Judith Agudo, et al.
Nature Chemical Biology
|
January 23, 2018
A whole-animal platform to advance a clinical kinase inhibitor into new disease space
Masahiro Sonoshita, Alex P Scopton, Peter M U Ung, et al.
Molecular Cancer Therapeutics
|
June 20, 2019
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology
Jia Xin Yu, Amanda J Craig, Mary E Duffy, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Progress in Nuclear Magnetic Resonance Spectroscopy
|
September 17, 2011
In-cell NMR spectroscopy
Andres Y Maldonado, David S Burz, Alexander Shekhtman
Plos One
|
September 17, 2013
Fate of pup inside the Mycobacterium proteasome studied by in-cell NMR
Andres Y Maldonado, David S Burz, Sergey Reverdatto, et al.
The Journal of Biological Chemistry
|
December 24, 2011
Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1
Vivek Rai, Andres Y Maldonado, David S Burz, et al.
Nature Communications
|
November 19, 2014
Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
Benjamin Israelow, Gavriel Mullokandov, Judith Agudo, et al.
Nature Chemical Biology
|
January 23, 2018
A whole-animal platform to advance a clinical kinase inhibitor into new disease space
Masahiro Sonoshita, Alex P Scopton, Peter M U Ung, et al.
Molecular Cancer Therapeutics
|
June 20, 2019
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology
Jia Xin Yu, Amanda J Craig, Mary E Duffy, et al.
Page
of 1